STOCK TITAN

T. Rowe Price holds 5.7% of Erasca (NASDAQ: ERAS) stock

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G reporting beneficial ownership of 16,111,414 shares of Erasca Inc. common stock, representing 5.7% of the class as of 12/31/2025.

The firm reports sole power to vote and dispose of all 16,111,414 shares, with no shared voting or dispositive power. It states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Erasca.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Investment Management, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:02/17/2026

FAQ

What percentage of Erasca (ERAS) does T. Rowe Price Investment Management report owning?

T. Rowe Price Investment Management reports beneficial ownership of 5.7% of Erasca’s common stock. This stake, disclosed on an amended Schedule 13G, reflects institutional-level ownership and can signal meaningful engagement with the company’s equity over time.

How many Erasca (ERAS) shares are beneficially owned according to this Schedule 13G/A?

The filing reports beneficial ownership of 16,111,414 shares of Erasca common stock. T. Rowe Price Investment Management indicates sole voting and sole dispositive power over all these shares, with no shared authority reported for voting or disposition.

As of what date is T. Rowe Price Investment Management’s Erasca (ERAS) ownership measured?

The ownership position is measured as of December 31, 2025. The Schedule 13G/A uses this date as the event that triggered the filing requirement, tying the 5.7% ownership and share count to that specific point in time.

Does T. Rowe Price Investment Management seek to influence control of Erasca (ERAS) with this stake?

The firm states the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Erasca, aligning with a passive investment intent disclosure.

What type of investor is T. Rowe Price Investment Management in relation to Erasca (ERAS)?

T. Rowe Price Investment Management is identified as an investment adviser filing on Schedule 13G. It reports beneficial ownership but also includes standard language denying that the filing should be construed as an admission of beneficial ownership.

What voting and dispositive powers does T. Rowe Price report over Erasca (ERAS) shares?

The firm reports sole voting power and sole dispositive power over 16,111,414 Erasca shares, with no shared voting or dispositive power. This means it alone can vote and decide on the disposition of these reported shares.
Erasca, Inc.

NASDAQ:ERAS

ERAS Rankings

ERAS Latest News

ERAS Latest SEC Filings

ERAS Stock Data

3.72B
380.34M
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO